The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122329126 12232912 6 F 20160224 20160809 20160402 20160811 EXP JP-AMGEN-JPNCT2016041754 AMGEN 59.00 YR A M Y 65.70000 KG 20160811 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122329126 12232912 1 PS panitumumab PANITUMUMAB 1 Intravenous drip 380 MG, Q2WEEKS 1520 MG 125147 380 MG SOLUTION FOR INJECTION QOW
122329126 12232912 2 SS ELPLAT OXALIPLATIN 1 Intravenous drip 150 MG, Q2WEEKS 600 MG U 0 150 MG QOW
122329126 12232912 3 SS ELPLAT OXALIPLATIN 1 600 MG U 0
122329126 12232912 4 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 4200 MG, Q2WEEKS 19600 MG U 0 4200 MG QOW
122329126 12232912 5 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 4200 MG, Q2WEEKS 19600 MG U 0 4200 MG QOW
122329126 12232912 6 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 200 MG/M2, Q2WEEKS U 0 200 MG/M**2 QOW
122329126 12232912 7 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 U 0
122329126 12232912 8 C MINOMYCIN MINOCYCLINE HYDROCHLORIDE 1 Oral 100 MG, QD U 0 100 MG QD
122329126 12232912 9 C HIRUDOID /00723702/ GLYCOSAMINOGLYCANS 1 Transdermal UNK U 0
122329126 12232912 10 C MYSER /01249201/ DIFLUPREDNATE 1 Transdermal UNK U 0
122329126 12232912 11 C LOCOID HYDROCORTISONE BUTYRATE 1 Transdermal UNK U 0
122329126 12232912 12 C HIRUDOID GLYCOSAMINOGLYCANS 1 Transdermal UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122329126 12232912 1 Colon cancer
122329126 12232912 2 Colon cancer
122329126 12232912 3 Colon cancer
122329126 12232912 4 Colon cancer
122329126 12232912 5 Colon cancer
122329126 12232912 6 Colon cancer
122329126 12232912 7 Colon cancer
122329126 12232912 9 Dry skin prophylaxis
122329126 12232912 10 Prophylaxis
122329126 12232912 11 Prophylaxis
122329126 12232912 12 Dry skin prophylaxis

Outcome of event

Event ID CASEID OUTC COD
122329126 12232912 OT
122329126 12232912 HO
122329126 12232912 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
122329126 12232912 Cardiac arrest
122329126 12232912 Infusion related reaction
122329126 12232912 Nausea
122329126 12232912 Palmar-plantar erythrodysaesthesia syndrome
122329126 12232912 Paronychia
122329126 12232912 Peripheral sensory neuropathy
122329126 12232912 Prinzmetal angina
122329126 12232912 Stomatitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122329126 12232912 1 20160224 20160406 0
122329126 12232912 2 20160224 20160406 0
122329126 12232912 4 20160224 20160406 0
122329126 12232912 5 20160224 20160406 0
122329126 12232912 6 20160224 20160406 0
122329126 12232912 8 20160224 0
122329126 12232912 9 20160224 0
122329126 12232912 10 20160224 0
122329126 12232912 11 20160224 0
122329126 12232912 12 20160224 0